The impact of comorbid COPD on survival outcomes in lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Front Immunol · 2025 · PMC12640801 · PMID 41293168

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Geographical analysis indicated significant PFS benefits in Asia (HR = 0.54), whereas OS did not reach statistical significance (HR = 0.83), potentially due to differences in subsequent therapies or insufficient follow-up.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.